164 related articles for article (PubMed ID: 6512004)
1. Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density.
Koller WC
J Clin Psychopharmacol; 1984 Dec; 4(6):343-5. PubMed ID: 6512004
[TBL] [Abstract][Full Text] [Related]
2. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission.
Calabresi P; De Murtas M; Mercuri NB; Bernardi G
Ann Neurol; 1992 Apr; 31(4):366-73. PubMed ID: 1350190
[TBL] [Abstract][Full Text] [Related]
3. Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
Fage D; Guerin B; Feuerstein C; Demenge P; Scatton B
Brain Res; 1984 Sep; 310(2):379-83. PubMed ID: 6488029
[TBL] [Abstract][Full Text] [Related]
4. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
Schweitzer JW; Schwartz R; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of tardive dyskinesia.
Klawans HL; Carvey P; Tanner CM; Goetz CG
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
[TBL] [Abstract][Full Text] [Related]
6. Dopamine binding following prolonged haloperidol pretreatment.
Hitri A; Weiner WJ; Borison RL; Diamond BI; Nausieda PA; Klawans HL
Ann Neurol; 1978 Feb; 3(2):134-40. PubMed ID: 655662
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
Gordon JH; Diamond BI
Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG).
Rajakumar G; Naas F; Johnson RL; Chiu S; Yu KL; Mishra RK
Peptides; 1987; 8(5):855-61. PubMed ID: 2893360
[TBL] [Abstract][Full Text] [Related]
9. Sensitive periods for the effect of haloperidol on development of striatal dopamine receptors.
Rosengarten H; Friedman E; Friedhoff AJ
Birth Defects Orig Artic Ser; 1983; 19(4):511-3. PubMed ID: 6871420
[No Abstract] [Full Text] [Related]
10. Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.
Friedhoff AJ; Bonnet K; Tosengarten H
Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):411-23. PubMed ID: 847296
[TBL] [Abstract][Full Text] [Related]
11. [Effect of pergolide on the kinetics of the dopamine receptors in the corpus striatum of the rat].
Jiang DH
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):209-13. PubMed ID: 4075909
[No Abstract] [Full Text] [Related]
12. Interaction of pergolide with central dopaminergic receptors.
Goldstein M; Lieberman A; Lew JY; Asano T; Rosenfeld MR; Makman MH
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3725-8. PubMed ID: 6932044
[TBL] [Abstract][Full Text] [Related]
13. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
Zharkovskiĭ AM; Matvienko OA; Nurk AM
Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic drugs and their action on different neuronal pathways.
Ungerstedt U; Herrera-Marschitz M; Forster C
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
[TBL] [Abstract][Full Text] [Related]
15. Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum.
Reches A; Wagner HR; Jackson-Lewis V; Yablonskaya-Alter E; Fahn S
Neurology; 1984 Sep; 34(9):1208-12. PubMed ID: 6540406
[TBL] [Abstract][Full Text] [Related]
16. Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding.
Schröder U; Schröder H; Augustin W; Sabel BA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1193-6. PubMed ID: 7996425
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
Wong DT; Threlkeld PG; Bymaster FP
Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
[TBL] [Abstract][Full Text] [Related]
18. The effect of ethanol and haloperidol on dopamine receptor (D2) density.
Fuchs V; Coper H; Rommelspacher H
Neuropharmacology; 1987 Aug; 26(8):1231-3. PubMed ID: 3658125
[TBL] [Abstract][Full Text] [Related]
19. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
[TBL] [Abstract][Full Text] [Related]
20. Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia.
Fuller RW; Clemens JA; Hynes MD
J Clin Psychopharmacol; 1982 Dec; 2(6):371-5. PubMed ID: 7174859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
